Sort by
Refine Your Search
-
Listed
-
Category
-
Field
-
Engineering ( https://engineering.pitt.edu/bioengineering ) is seeking a Research Assistant Professor (Appointment Stream). Incumbent must possess a PhD in Bioengineering, Neuroscience, Neurobiology
-
, purification and titration of virus stock s (plaque assay and/or TCID50), design and execution of infection time-course experiments, Mammalian cell culture and aseptic technique, including primary
-
-generation viral vector technologies for precision gene therapy. The Ingusci Laboratory engineers replication-defective and replication-competent herpes simplex virus (HSV) vectors for the delivery of large
-
separately. Our hearing research community is further supported by certificate graduate programs and NIH-funded training grants ( https://phrc.pitt.edu/education-training ) dedicated to the training
-
shared resources that receive funding from our NCI Cancer Center Support Grant https://hillmanresearch.upmc.edu/research/; and a 2022 institutional funding base of nearly $150 million. In 2022, the
-
research focused on the molecular mechanisms underlying virus-associated cancers and the identification of novel therapeutic strategies. Responsibilities include designing and conducting innovative
-
educational benefits. Information about these and other benefits can be found on the University’s HR website: https://www.hr.pitt.edu/current-employees/benefits . Apply Now: Applications will be
-
population sciences; ten shared resources that receive funding from our NCI Cancer Center Support Grant https://hillmanresearch.upmc.edu/research/ ; and a 2022 institutional funding base of nearly
-
Position Description The Pittsburgh Particle Physics, Astrophysics and Cosmology Center (PITT PACC, https://www.pittpacc.pitt.edu/ ) at the University of Pittsburgh invites applications for the
-
, plasmid transfection, virus transduction, basic cellular function measurements such as cell death, apoptosis, proliferation. Molecule cloning. Generate genetically modified cell lines using CRISPR-Cas9